Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
What Is Squamous Cell Carcinoma In Situ? Causes, Treatment & Recovery.
What Is Squamous Cell Carcinoma In Situ? Causes, Treatment & Recovery. 4

Getting a diagnosis of squamous cell carcinoma in situ can be scary. But we’re here to help you understand it. This is an early, non-invasive skin problem. It stays in the top layer of your skin, called the epidermis.

This quamous cell skin cancer in situ hasn’t spread to deeper tissues. So, it’s very treatable. Early detection can lead to a 99 percent chance of survival after five years. We want you to know that with quick medical care, you can fully recover and keep your health safe.

Key Takeaways

  • This condition is a non-invasive form of skin cancer limited to the epidermis.
  • Early diagnosis is the most critical factor for successful treatment outcomes.
  • Patients often achieve a 99 percent survival rate when treated promptly.
  • Professional medical intervention prevents the condition from becoming invasive.
  • We provide complete support to help you navigate your recovery journey with peace of mind.

Understanding Squamous Cell Carcinoma In Situ

Understanding Squamous Cell Carcinoma In Situ
What Is Squamous Cell Carcinoma In Situ? Causes, Treatment & Recovery. 5

Medical terms can be scary, but we’re here to make them simple. We break down carcinoma in situ of the skin to help you understand. This way, you can make better choices for your health.

Defining Intraepidermal Carcinoma and Bowen Disease

It’s easy to get confused by different names for the same thing. But, intraepidermal carcinoma and Bowen disease are just other names for squamous cell carcinoma in situ.

This condition is a type of skin cancer that stays in the outer skin layer. It’s treatable if caught early, because the cancer hasn’t spread.

— Clinical Dermatology Research Group

The Rising Global Incidence of SCC In Situ

Recent studies show a big increase in scc in situ cases. Between 2005 and 2023, the number of cases went up by 6.4 percent in men and 5.8 percent in women each year.

Studies from the Netherlands show the trend clearly. They found that women had 72 cases per 100,000 person-years, and men had 68.

MetricMale IncidenceFemale Incidence
Annual Growth Rate6.4%5.8%
Netherlands Rate (per 100k)6872
Primary ConcernEarly DetectionEarly Detection

Distinguishing In Situ from Invasive Skin Cancer

Knowing the difference between in situ scc and invasive skin cancer is key. In situ means the cancer is only on the surface. But, invasive cancer can spread deeper.

We stress that ec skin cancer in its early stages is easier to treat. By knowing the difference, you can get the right care early. This is your best defense against bowen disease or owen’s disease.

Risk Factors and Clinical Progression

Risk Factors and Clinical Progression
What Is Squamous Cell Carcinoma In Situ? Causes, Treatment & Recovery. 6

Understanding how skin conditions progress helps us care for our patients better. We focus on finding the triggers for n situ squamous cell carcinoma. This way, we can guide you to the best care for your skin.

Primary Drivers: Ultraviolet Exposure and Environmental Factors

The biggest factor in owens disease skin is UV radiation. This damage builds up over years, mainly for those who spend a lot of time outside without protection.

Environmental toxins like arsenic also play a part in owens dis. These conditions often show up on sun-exposed areas like the scalp, ears, and neck.

The Role of Chronic Immunosuppression and Precursor Lesions

People with weak immune systems are more at risk for owen diseae. A weakened immune system makes it hard for the skin to fix itself, leading to lasting damage.

We watch for early signs like actinic keratosis on the owen’s disease face. These spots are a sign that the skin needs professional care.

— Clinical Dermatology Guidelines

Progression Rates and the Importance of Early Detection

owens disease is manageable if caught early. Without treatment, about 3 to 5 percent of cases can turn invasive. Regular checks are key.

When we look at owen’s disease skin, we focus on any changes in texture or color. Spotting s bowen’s disease cancer risks early helps us stop it from getting worse.

If you see any owen’s disease symptoms, contact our team for a full check-up. We’re here to help you on your path to recovery and better skin.

Risk FactorImpact LevelClinical Focus
UV ExposureHighSun-exposed areas
ImmunosuppressionModerateSystemic health
Precursor LesionsHighEarly monitoring
Arsenic ExposureLowEnvironmental history

Conclusion

Managing your skin health is all about being proactive. Spotting changes early is key to good outcomes. We offer care that fits your medical history and lifestyle.

Choosing the right treatment for quamous carcinoma in situ is important. Our experts use advanced methods to remove bad cells safely. We make sure you’re comfortable and healthy throughout your care.

Today’s medicine offers many ways to treat these lesions. We might use surgery or creams, depending on what you need. At Medical organization and other top places, we aim for the best results for you.

Starting your recovery is as simple as talking about your skin worries. Contact our team to set up a meeting. We’re here to guide you and help you feel good about your skin again.

FAQ

What is squamous cell carcinoma in situ and how does it differ from invasive skin cancer?

Squamous cell carcinoma in situ is an early, non-invasive form of skin cancer where abnormal squamous cells are confined to the outer layer of the skin (epidermis). It differs from invasive skin cancer because it has not yet penetrated deeper layers or spread to other tissues.

Are Bowen disease and intraepidermal carcinoma the same condition?

Yes, Bowen disease and intraepidermal carcinoma are the same condition, both referring to squamous cell carcinoma in situ. The terms are used interchangeably in clinical practice.

What are the common Bowen disease symptoms I should look for?

Bowen disease typically appears as a persistent, slowly growing, red or scaly patch on the skin. It may become crusted, itchy, or slightly raised over time.

What are the primary causes of squamous cell skin cancer in situ?

The main causes include long-term UV exposure, aging, fair skin, immune suppression, and exposure to carcinogenic chemicals like arsenic. Chronic skin damage also increases risk.

What is the recommended squamous carcinoma in situ treatment?

Treatment options include surgical excision, cryotherapy, topical chemotherapy creams, or photodynamic therapy depending on lesion size and location. Most cases are highly treatable when detected early.

What is the survival rate for individuals diagnosed with intraepidermal carcinoma?

The prognosis is excellent because it is a non-invasive form of skin cancer. With appropriate treatment, cure rates are very high.

Is the incidence of Bowen’s disease increasing?

Yes, the incidence of Bowen’s disease has been increasing, largely due to aging populations, higher UV exposure, and improved detection rates.

References:

The Lancet. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(08)70191-X/fulltext

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01